Example collocations logo

Vaccine in sentence

824 examples of Vaccine in a sentence

During the 2009 swine flu pandemic, a few countries cornered the vaccine market, leaving the vast majority of the global population with no vaccine at all until the outbreak was effectively over.
COVAX ensures that the benefits and risks of vaccine development are broadly shared.
With the largest portfolio of vaccine candidates anywhere in the world, it gives participating governments the best odds of receiving a safe and effective vaccine as soon as it becomes available – and ensures that this moment comes much sooner.
When pharmaceutical companies are shouldering all of the financial risks, they will invest in scaling up production only after their vaccine has completed clinical trials and been approved.
This provides powerful incentives for the private sector to support urgent vaccine development.
That way, when approval comes, large quantities of vaccine doses will be ready to go.
Already, WHO is working with a range of stakeholders, including member states and civil-society organizations, to develop and implement a mechanism for equitable and fair allocation of vaccine doses, once they become available.
COVAX will support only vaccine candidates that are developed in accordance with the highest possible safety standards.
By working with experts around the world to develop target product profiles, share best-practice testing models, facilitate multi-country clinical trials, and promote regulatory harmonization, COVAX will establish a new benchmark for rapid, safe, and efficacious vaccine development and delivery.
The goal is to buy time until the warmer months arrive, or until a vaccine has been developed (the “research” phase) and widely deployed.
The US Economy Needs a Booster ShotBERKELEY – November brought welcome news from Pfizer, Moderna, and AstraZeneca, each of which is reporting high levels of effectiveness for its COVID-19 vaccine.
Hopes that vaccine distribution will begin by early December have pushed stock-market indexes to near-record levels.
This will make it much harder to develop a reliable vaccine.
Will he withhold information about Operation Warp Speed, the government’s effort to produce a COVID-19 vaccine?
The risk of returning to work and school will not fall to zero until an effective vaccine has become widely available, or until the population has achieved “herd immunity.”
The private sector is working hard on a vaccine, and this is commendable.
NEW YORK – A safe and effective vaccine could play a significant role in mitigating the COVID-19 pandemic.
Yet, even if such a vaccine is found, it is highly unlikely that a sufficient number of doses could be produced in the next 2-3 years to ensure equitable access for everyone.
So, when a COVID-19 vaccine becomes available, who should get it first?
But there is little consensus about how a COVID-19 vaccine should be allocated beyond this group.
This reflects the CDC’s pre-COVID-19 tendency to emphasize the securitization of health: an influenza vaccine, the guidelines state, should be allocated in a way that will “maintain national security, health care, and other essential community services.”
They suggest that after health-care workers are vaccinated, a lottery system would be the most equal way to allocate a limited supply of the vaccine .
The ironically titled Inclusive Vaccine Alliance shows how vaccine sovereignty reproduces global inequity.
During the COVID-19 crisis, that means giving BIPOC communities priority access, alongside health-care workers, to a vaccine.
Giving BIPOC communities priority access to a COVID-19 vaccine must not be confused with reparations for slavery and colonialism.
It will take much more than a vaccine to address the systemic injustices of white supremacy.
That’s true of the COVID-19 infection rate, as well as the unprecedented scientific efforts under way to find a vaccine.
Today, national COVID-19 strategies can be broadly separated into three categories: eradication, herd immunity, and suppression of the coronavirus until a vaccine or cure is discovered.
This may sound like a utopian fantasy, but it is actually a description of how the flu vaccine has been produced for the past 50 years.
Through the World Health Organization’s Global Influenza Surveillance and Response System, experts from around the world convene twice a year to analyze and discuss the latest data on emerging flu strains, and to decide which strains should be included in each year’s vaccine.
BackNext